Valiant Navion™ VNMC2828C90TU (UDI 00763000100957)Recalls & reported problems
Medtronic, Inc. · STENT GRAFT VNMC2828C90TU VAL NAV CS · Class 3 · Implant
All models of Valiant Navion (137)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 7
- Deaths reported
- 2
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 7 adverse event reports that list this exact device (DI 00763000100957), received between Nov 9, 2021 and Sep 23, 2024 — classified as 2 deaths, 2 injuries, 3 malfunctions.
The most frequently reported specific device problem is “Leak/Splash” (5 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Leak/Splash5
- Adverse Event Without Identified Device or Use Problem2
Patient problems
- No Clinical Signs, Symptoms or Conditions3
- Hemorrhage/Blood Loss/Bleeding2
- Rupture2
- Abdominal Pain1
- Anemia1
- Aneurysm1
- Cardiac Tamponade1
- Fistula1
Recent adverse event reports
The 7 most recent of 7 reports, in the reporter's own words as published by the FDA.
MalfunctionSep 23, 2024Leak/Splash; Leak/Splash
TWO VALIANT NAVION STENT GRAFTS WERE IMPLANTED DURING THE ENDOVASCULAR TREATMENT OF A THORACIC AORTIC DISSECTION. IT WAS REPORTED COREL LAB REVIEW OF CT IMAGING FROM APPROXIMATELY 3 YEARS POST THE INDEX PROCEDURE IDENTIFIED A NEW TYPE IA ENDOLEAK IN VNMC2828C90TU S/N (B)(6). NO FRACTURE, STENT RING ENLARGEMENT, STENT RING MIGRATION OR STENT RING DETACHMENT WAS OBSERVED. THE MAX AORTIC DIAMETER WAS 46.8MM. NO AORTIC ENLARGEMENT WAS OBSERVED. THE CAUSE OF THE ENDOLEAK IS UNDETERMINED. NO ADDITIONAL CLINICAL SEQUALAE WERE PROVIDED AND THE PATIENT IS FINE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20279702 ↗MalfunctionJun 26, 2024Leak/Splash; Leak/Splash
VALIANT NAVION STENT GRAFTS WERE IMPLANTED DURING THE ENDOVASCULAR TREATMENT OF AN TAA. THE PATIENT HAD 4 EXISTING VALIANT CAPTIVIA GRAFTS IMPLANTED 6 YEARS PREVIOUS. IT WAS REPORTED CORE LAB REVIEW OF CT IMAGING FROM APPROXIMATELY 3 YEARS POST THE NAVION IMPLANT, SHOWED A IB ENDOLEAK ON VNMC2828C90TU ((B)(6)). NO STENT FRACTURE, STENT RING ENLARGEMENT OR STENT RING MIGRATION WAS OBSERVED. THE MAXIMUM AORTIC DIAMETER WAS NOTED AS 59.5MM. DEVICE ORDER ON IMAGING WAS NOT CONFIRMED. A NON NAVION TYPE IA ENDOLEAK WAS OBSERVED PROXIMALLY. THE CAUSE OF THE ENDOEAKS ARE UNDETERMINED. NO ADDITIONAL CLINICAL SEQUALAE WERE PROVIDED AND THE PATIENT WILL BE MONITORED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19615579 ↗InjuryFeb 3, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
VALIANT NAVION THORACIC STENT GRAFTS WERE IMPLANTED FOR THE TREATMENT OF AN UNKNOWN SIZE ANEURYSM ON (B)(6) 2020. IT WAS REPORTED APPROXIMATELY 1 YEAR POST THE INDEX PROCEDURE, ON (B)(6) 2021 SHOWED AORTIC ENLARGEMENT (42MM COMPARED TO 39MM PREVIOUS). A SECONDARY PROCEDURE TO REPAIR THE DILATED DESCENDING AORTA WHERE A NON MDT GRAFT AND A THORACIC ABDOMINAL GRAFT WAS COMPLETED. IT WAS REPORTED APPROXIMATELY 2 YEARS POST THE INDEX PROCEDURE, CT SHOWED AN INCREASE IN AORTIC DIMENSION IN DISTAL ARCH AND DESCENDING THORACIC AORTA, WHICH NOW MEASURES 47MM, WAS NOTED. CORELAB REVIEW OF CT IMAGING FROM ON (B)(6) 2022 IDENTIFIED A TYPE IA ENDOLEAK INVOLVING VNMC3434C90TU (V29531128). THERE WAS NO STENT FRACTURE, STENT RING ENLARGEMENT OR STENT RING DETACHMENT OBSERVED. NO CAUSE OF ENDOLEAK PROVIDED. THE CAUSE OF THE EVENT IS UNKNOWN. NO ADDITIONAL SEQUELAE WAS REPORTED AND THE PATIENT WILL BE MONITORED.
Patient problems: Aneurysm
MAUDE report 16291227 ↗InjuryJan 16, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A VALIANT NAVION STENT GRAFT WAS IMPLANTED DURING THE ENDOVASCULAR TREATMENT OF A LEFT ABERRANT SUBCLAVIAN ARTERY. IT WAS REPORTED APPROXIMATELY 2 YEARS POST THE INDEX PROCEDURE FOLLOW UP CT SHOWED COMPLETE OCCLUSION OF THE STENTED RIGHT EXTERNAL ILIAC AND COMMON FEMORAL ARTERIES. PER THE PHYSICIAN THE CAUSE OF THE OCCLUSION WAS DUE TO FURTHER PROGRESSION OF PAD. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT WILL BE MONITORED.
Patient problems: Obstruction/Occlusion
MAUDE report 16173032 ↗MalfunctionJan 13, 2023Leak/Splash; Leak/Splash
VALIANT NAVION STENT GRAFT WERE IMPLANTED IN THE ENDOVASCULAR TREATMENT OF A TAA. IT WAS REPORTED ON THE DATE OF THE CT, AN UNDETERMINED SMALL TYPE I ENDOLEAK WAS OBSERVED. NO CAUSE WAS REPORTED. NO ADDITIONAL CLINICAL SEQUALAE WERE PROVIDED AND THE PATIENT WILL BE MONITORED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 16155727 ↗DeathNov 18, 2022Leak/Splash; Leak/Splash
VALIANT NAVION STENT GRAFTS WERE IMPLANTED IN THE ENDOVASCULAR TREATMENT OF A DISSECTION. IT WAS REPORTED ABOUT 18 MONTHS LATER, THE PATIENT PRESENTED TO THE EMERGENCY ROOM WITH HEMOPTYSIS. A CT PERFORMED REVEALED A LARGE PSEUDOANEURYSM AND TYPE I ENDOLEAK. THE PATIENT THEN EXPIRED. APLASTIC ANEMIA WAS ALSO NOTED. THE CAUSE OF THE EVENT IS UNKNOWN. NO ADDITIONAL CLINICAL SEQUALAE WERE PROVIDED AND THE PATIENT IS EXPIRED.
Patient problems: Anemia; Cardiac Tamponade; Hemorrhage/Blood Loss/Bleeding; Pneumothorax; Pseudoaneurysm; Respiratory Failure; Rupture; Thrombocytopenia; Unspecified Infection; Vascular Dissection
MAUDE report 15825603 ↗DeathNov 9, 2021Leak/Splash; Leak/Splash
A VALIANT NAVION STENT GRAFT SYSTEM WAS IMPLANTED DURING AN UNKNOWN THORACIC ENDOVASCULAR PROCEDURE. IT WAS REPORTED 15 DAYS POST THE INDEX PROCEDURE THE PATIENT PRESENTED EMERGENTLY. A CT SCAN PERFORMED SHOWED EXTRAVASATION FROM THE GRAFT AND THE PATIENT HAD HEMATEMESIS. IT WAS REPORTED THAT THE PATIENT EXPIRED ON THE DAY THEY PRESENTED. AS PER THE PHYSICIAN THE CAUSE OF HEMATEMESIS AND EXTRAVASATION IS UNDETERMINED. THE CAUSE OF DEATH WAS A RESULT OF HEMATEMESIS AND EXTRAVASATION. NO ADDITIONAL CLINICAL SEQUALAE WAS PROVIDED AND THE PATIENT HAS EXPIRED.
Patient problems: Abdominal Pain; Fistula; Hematemesis; Hemorrhage/Blood Loss/Bleeding; Rupture
MAUDE report 12777849 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page